Biotech & MedTech
-
Dr. Carolyn Myers on FendX Technologies’ Breakthrough Film Formulation that Kills and Repels Bacteria
In an insightful interview with Tracy Weslosky from Investor.Coffee, Dr. Carolyn Myers, President, CEO, and Director of FendX…
-
Greg Fenton on how Zentek’s Advancement in Aptamer Technology is Revolutionizing Biotech
In an interview with host Tracy Weslosky from InvestorNews, Zentek Ltd.‘s (NASDAQ: ZTEK | TSXV: ZEN) CEO Greg…
-
Progress in Pathogen Defense, Dr. Carolyn Myers Discusses FendX’s Collaboration with Dunmore for REPELWRAP™
In a recent interview with InvestorNews host Tracy Weslosky, FendX Technologies Inc.’s (CSE: FNDX | OTCQB: FDXTF) President, CEO,…
-
Greg Fenton on China’s graphite export restrictions and Zentek’s Albany graphite deposit in Ontario
In a recent InvestorNews interview with host Tracy Weslosky, Zentek Ltd.’s (NASDAQ: ZTEK | TSXV: ZEN) CEO and…
-
Exploring the FendX strategic vision for products focused on infectious disease control with Dr. Carolyn Myers
In a recent interview with Investor.News host Tracy Weslosky, FendX Technologies Inc.’s (CSE: FNDX | OTCQB: FDXTF) President,…
-
InvestorNews Today: Zentek, Australian Strategic Materials and the Global Markets
August 28, 2023 — Enjoying the new name for InvestorIntel, we are in the final countdown for a…
-
FendX Technologies is a germaphobes new best friend
How often do you find yourself with subtle post pandemic habits, like pushing doors open with your elbow…
-
FendX Technologies’ award winning nanotechnology and REPELWRAP™ film is advancing at warp speed
One day in the future there could be special nanomaterials used in hospitals, operating theaters, and medical clinics…
-
With an effective anti-inflammatory and anti-fibrotic agent, Cardiol Therapeutics is focused on our hearts
Trialing cannabidiol-based therapies for pericarditis and myocarditis while developing new therapies for heart failure — Cardiol is well-capitalized…
